黃佳 諸琦 曹海霞 姚瑋艷 章永平 袁耀宗
·論著·
XAF1基因誘導(dǎo)胰腺癌細(xì)胞株BxPC3凋亡的實(shí)驗(yàn)研究
黃佳 諸琦 曹海霞 姚瑋艷 章永平 袁耀宗
目的探討Ad5/F35腺病毒介導(dǎo)的XAF1基因誘導(dǎo)胰腺癌細(xì)胞BxPC3凋亡及其可能的作用機(jī)制。方法將前期構(gòu)建的重組腺病毒Ad5/F35-XAF1感染胰腺癌細(xì)胞BxPC3。采用半定量RT-PCR、蛋白質(zhì)印跡檢測(cè)法檢測(cè)感染前后BxPC3細(xì)胞XAF1 mRNA和蛋白表達(dá)的變化;運(yùn)用Annexin-V/PI和TUNEL法檢測(cè)細(xì)胞的凋亡率;免疫蛋白印跡法檢測(cè)細(xì)胞Caspase-3、PARP、Caspase-8和Bcl-2蛋白的表達(dá)。結(jié)果Ad5/F35-XAF1感染后,BxPC3細(xì)胞的XAF1 mRNA和蛋白表達(dá)明顯增高,與空白組和Ad5/F35-Null對(duì)照組比較,差異顯著(Plt;0.05);兩種方法檢測(cè)的細(xì)胞凋亡率分別為(19.90±3.09)%、(9.29±2.13)%,較Ad5/F35-Null組的(6.72±0.76)%、(2.73±0.51)%和空白組的(7.22±1.53)%、(1.56±0.47)%均有顯著差異(Plt;0.01);Caspase-3、PARP、Caspase-8蛋白表達(dá)顯著增強(qiáng),Bcl-2表達(dá)降低。結(jié)論Ad5F35-XAF1重組腺病毒感染胰腺癌細(xì)胞BxPC-3能明顯誘導(dǎo)細(xì)胞的凋亡,其機(jī)制可能是激活死亡受體途徑和線粒體途徑。
胰腺腫瘤; 腺病毒; XAF1基因; 細(xì)胞凋亡
X染色體連接的凋亡抑制蛋白(X-linked inhibitor of apoptosis, XIAP)是凋亡核心介導(dǎo)因子——凋亡抑制蛋白家族中作用最強(qiáng)的成員[1],而XIAP相關(guān)因子1(XIAP-Associated Factor 1,XAF1)是XIAP負(fù)性調(diào)節(jié)因子之一。它在所有胚胎組織及成人正常組織中廣泛表達(dá),但在許多腫瘤組織和腫瘤細(xì)胞株中低表達(dá)甚至不表達(dá)[2],提示XAF1是一種潛在的腫瘤抑制因子。本實(shí)驗(yàn)應(yīng)用前期構(gòu)建的重組腺病毒Ad5/F35-XAF1[3],觀察其對(duì)胰腺癌細(xì)胞BxPC3凋亡的影響。
一、重組腺病毒感染人胰腺癌細(xì)胞株BxPC3
重組腺病毒Ad5/F35-XAF1及陰性對(duì)照腺病毒Ad5/F35-Null由本實(shí)驗(yàn)室前期構(gòu)建。常規(guī)培養(yǎng)人胰腺癌細(xì)胞株BxPC3,細(xì)胞貼壁生長(zhǎng)24 h后,將Ad5/F35-XAF1和Ad5/F35-Null用無(wú)血清DMEM培養(yǎng)基稀釋后感染細(xì)胞。2 h后更換含10%胎牛血清的培養(yǎng)液,常規(guī)培養(yǎng)箱中培養(yǎng)48 h。
二、XAF1mRNA檢測(cè)
采用Trizol(Invitrogen公司)法提取細(xì)胞總RNA。運(yùn)用MMLV第一鏈cDNA合成試劑盒(上海生工生物公司)合成cDNA。XAF1引物序列:上游5′-TCCGGAATTCATGCTCCACGAGTCCTACTG-3′,下游5′-ACGCGTCGACAAACTCTGAGTCTGGACAAC-3′,產(chǎn)物大小260 bp;β-actin引物序列:上游5′-ATCTGGCACCACACCTTCTACAATGAGCTGC-3′,下游5′-CGTCATACTCCTGCTTGCTGATCCACATCTGC-3′,產(chǎn)物大小830 bp。PCR反應(yīng)后產(chǎn)物行1.5%的瓊脂糖凝膠電泳,Bio-rad凝膠成像系統(tǒng)攝影。
三、XAF1、Caspase-3、PARP 、Caspase-8和Bcl-2蛋白檢測(cè)
用細(xì)胞裂解液(申能博彩公司)抽提細(xì)胞總蛋白。取20 μg蛋白常規(guī)行免疫蛋白印跡。抗β-actin一抗1∶5000稀釋?zhuān)筙AF1一抗、抗Caspase-3、抗PARP、抗Caspase-8和抗Bcl-2一抗均1∶1000稀釋。最后ECL顯影。
四、細(xì)胞凋亡率檢測(cè)
取Ad5/F35-XAF1和Ad5/F35-Null感染細(xì)胞,制成單細(xì)胞懸液,調(diào)整細(xì)胞濃度為105~106個(gè)/ml。取細(xì)胞懸液490 μl,應(yīng)用Annexin-V/PI法及TUNEL法檢測(cè)細(xì)胞凋亡率,均重復(fù)3次。
五、統(tǒng)計(jì)學(xué)分析
用SPSS13.0統(tǒng)計(jì)軟件進(jìn)行分析。多組間均數(shù)比較采用單向方差分析,計(jì)數(shù)資料采用χ2檢驗(yàn),Plt;0.05為差異有統(tǒng)計(jì)學(xué)意義。
一、BxPC3細(xì)胞的XAF1 mRNA 和蛋白的表達(dá)
Ad5/F35-XAF1感染BxPC3細(xì)胞48 h后,XAF1 mRNA和蛋白的表達(dá)明顯增高,而空白組和Ad5/F35-Null組細(xì)胞的XAF1 mRNA和蛋白的表達(dá)水平很低或不表達(dá)(圖1),差異具有顯著性(Plt;0.05)。
二、BxPC3細(xì)胞凋亡率的變化
采用Annexin-V/PI法,Ad5/F35-XAF1感染BxPC3細(xì)胞48 h后,早期凋亡率為(19.90±3.09)%,與Ad5/F35-Null組(6.72±0.76)%和空白組(7.22±1.53)%相比,差異顯著(圖2,Plt;0.01);采用TUNEL法,感染BxPC3細(xì)胞48 h后細(xì)胞的凋亡率為(9.29±2.13)%,而Ad5/F35-Null組和空白組分別為(2.73±0.51)%和(1.56±0.47)%,差異均具有顯著性(圖3,Plt;0.01)。

圖1 感染前(下)、后(上)BxPC3細(xì)胞XAF1的表達(dá)

圖2 流式細(xì)胞儀檢測(cè)BxPC3細(xì)胞凋亡率
三、BxPC3細(xì)胞Caspase-3、PARP、Caspase-8和Bcl-2蛋白表達(dá)的變化
Ad5/F35-XAF1感染后,BxPC3細(xì)胞Caspase-3、PARP和Caspase-8蛋白表達(dá)顯著增強(qiáng),而B(niǎo)cl-2的表達(dá)明顯降低,較Ad5/F35-Null組和空白組均有顯著性差異(圖4)。

圖3TUNEL法檢測(cè)Ad5/F35-XAF1感染48 h后BxPC3細(xì)胞的凋亡

圖4 各組BxPC3細(xì)胞凋亡相關(guān)蛋白的表達(dá)
XAF1是新近發(fā)現(xiàn)的一種腫瘤抑制基因,能通過(guò)細(xì)胞外信號(hào)調(diào)節(jié)激酶途徑促進(jìn)結(jié)腸癌細(xì)胞的凋亡[4],并且可以增加腫瘤細(xì)胞對(duì)抗腫瘤藥物致凋亡作用的敏感性[5]。小鼠內(nèi)皮細(xì)胞過(guò)度表達(dá)XAF1,能誘導(dǎo)內(nèi)皮細(xì)胞的凋亡并且抑制血管的生成[6]。史冬梅等[7]報(bào)道XAF1能抑制肝癌細(xì)胞的增殖和誘導(dǎo)凋亡,并增加肝癌細(xì)胞對(duì)5-氟尿嘧啶和羥基喜樹(shù)堿的敏感性。本實(shí)驗(yàn)結(jié)果顯示,重組腺病毒Ad5/F35-XAF1感染胰腺癌細(xì)胞BxPC3 48 h后,XAF1 mRNA和蛋白的表達(dá)明顯增高,凋亡率顯著增加,說(shuō)明胰腺癌細(xì)胞過(guò)度表達(dá)XAF1能夠明顯誘導(dǎo)細(xì)胞的凋亡。
Liston等[8]研究發(fā)現(xiàn),XAF1與XIAP結(jié)合后使其重定位于細(xì)胞核,它通過(guò)競(jìng)爭(zhēng)性拮抗XIAP對(duì)caspase-3的抑制作用以激活Caspase-3,-7,-9的活性。本結(jié)果顯示,胰腺癌細(xì)胞株BxPC3過(guò)度表達(dá)XAF1后,caspase-3、PARP和caspase-8的活化都明顯增強(qiáng)。新近的研究表明,除了拮抗XIAP的作用之外,XAF1還能激活線粒體凋亡途徑,促進(jìn)細(xì)胞色素C的釋放,進(jìn)而增強(qiáng)TNFα誘導(dǎo)的由死亡受體介導(dǎo)的凋亡作用[9-10]。胰腺Bcl-2是一種原癌基因,過(guò)度表達(dá)的Bcl-2能抑制線粒體的通透性,阻止細(xì)胞色素C等凋亡蛋白釋放到胞質(zhì)中從而抑制細(xì)胞凋亡[11]。本實(shí)驗(yàn)證實(shí),胰腺癌細(xì)胞株BxPC3過(guò)度表達(dá)XAF1后,Bcl-2的表達(dá)水平較對(duì)照組明顯降低,說(shuō)明線粒體途徑也可能參與XAF1誘導(dǎo)的胰腺癌細(xì)胞的凋亡。
[1] Deveraux QL,Reed JC.IAP family proteins-suppressor of apoptosis.Genes Dev,1999,13:239-252.
[2] Liston P,Fong WG,Korneluk RG.The inhibitors of apoptosis:there is more to life than Bcl2.Oncogene,2003,22:8568-8580.
[3] 康焱,廖威明,袁振華,等.重組35型腺病毒介導(dǎo)人骨形成蛋白基因?qū)χ驹葱愿杉?xì)胞的誘導(dǎo)分化.中國(guó)修復(fù)重建外科雜志,2007,21:125-129.
[4] Yu LF,Wang J,Zou B,et al.XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer.Cancer,2007,10:1996-2003.
[5] Leaman DW,Chawla-Sarkar M,Vyas K,et al.Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.J Biol Chem,2002,277:28504-28511.
[6] Qiao L,Gu Q,Dai Y,et al.XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells.Tumour Biol,2008,29:122-129.
[7] 史冬梅,馬天樂(lè),涂水平,等.X-染色體相關(guān)凋亡抑制蛋白相關(guān)因子1抑制肝癌細(xì)胞增殖和誘導(dǎo)凋亡的實(shí)驗(yàn)研究.中華消化雜志,2006,26:682-685.
[8] Liston P,Fong WG,Kelly NL,et al.Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.Nat Cell Biol,2001,3:128-133.
[9] Xia Y,Novak R,Lewis J,et al.Xaf1 can cooperate with TNFalpha in the induction of apoptosis,independently of interaction with XIAP.Mol Cell Biochem,2006,286:67-76.
[10] Straszewski-Chavez SL,Visintin IP,Karassina N,et al.XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway.J Biol Chem,2007,282:13059-13072.
[11] Yang J,Liu X,Bhalla K,et al.Prevention of apoptosis by Bcl-2:release of cytochrome c from mitochondria blocked.Science,1997,275:1129-1132.
2008-12-10)
(本文編輯:呂芳萍)
XAF1genemediatedbyrecombinantadenovirusinducesapoptosisinpancreaticcelllineBxPC-3
HUANG Jia,ZHU Qi,CAO Hai-xia,YAO Wei-yan,ZHANG Yong-ping,YUAN Yao-zong.
Department of Gastroenterology, Ruijin Hospital,Medical School, Shanghai Jiaotong University, Shanghai 200025,China
ZHUQi,Emailzhuqi@medmail.com.cn
ObjectiveTo investigate whether expression of XAF1 mediated by adenovirus vector Ad5/F35 could induce apoptosis in pancreatic cancer cell line BxPC-3 and its possible mechanisms.MethodsPre-constructed recombinant Ad5/F35-XAF1 virus and negative control Ad5/F35-Null was tranfected into BxPC3; the expression of XAF1 mRNA and protein before and after tranfection was analyzed by semi-quantitative RT-PCR and Western blot. The expressions of proteins including Caspase-3, PARP, Caspase-8 and bcl-2 were detected by Western blots. Cell apoptosis was assessed by Annexin-V/PI and TUNEL staining.ResultsAfter Ad5/F35-XAF1 tranfection, XAF1 mRNA and protein expression significantly increased, and the difference was statistically significant when compared with control group and Ad5/F35-Null group (Plt;0.05). The apoptosis rate was (19.90±3.09)% and (9.29±2.13)%, which was significantly different (Plt;0.01) from those in the Ad5/F35-Null group [(6.72±0.7)6%, (2.73±0.51)%] or in the control group [(7.22±1.53)%, (1.56±0.47)%]. The expression of Caspase-3, PARP and Caspase-8 significantly increased, but the expression of bcl-2 decreased.ConclusionsXAF1 plays a major role in the apoptosis of pancreatic cancer that acts through the activation of death receptor pathway and mitochondrial pathway of apoptosis.
Pancreatic neoplasms; Adenoviruses; XAF1 genes; Apoptosis
10.3760/cma.j.issn.1674-1935.2009.05.016
200025 上海,上海交通大學(xué)醫(yī)學(xué)院附屬瑞金醫(yī)院消化內(nèi)科
諸琦,Email:zhuqi@medmail.com.cn